SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-18-000007
Filing Date
2018-05-09
Accepted
2018-05-09 08:14:48
Documents
67
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a03311810-q.htm 10-Q 1203314
2 EXHIBIT 5.1 cantoratmlegalopinion.htm EX-5.1 14795
3 EXHIBIT 10.1 cantoratmagreementmay2018.htm EX-10.1 317781
4 EXHIBIT 31.1 a033118ex311.htm EX-31.1 14798
5 EXHIBIT 31.2 a033118ex312.htm EX-31.2 14045
6 EXHIBIT 32.1 a033118ex321.htm EX-32.1 11763
13 arraylogo2018.jpg GRAPHIC 146580
  Complete submission text file 0001100412-18-000007.txt   7847113

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT arry-20180331.xml EX-101.INS 1666675
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20180331.xsd EX-101.SCH 51620
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20180331_cal.xml EX-101.CAL 70677
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20180331_def.xml EX-101.DEF 342389
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20180331_lab.xml EX-101.LAB 718539
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20180331_pre.xml EX-101.PRE 459726
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 18816748
SIC: 2834 Pharmaceutical Preparations